Ninety One North America’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-71,843
Closed -$7.5M 117
2017
Q4
$7.5M Sell
71,843
-16,519
-19% -$1.86M 1.19% 37
2017
Q3
$12.9M Buy
88,362
+3,102
+4% +$423K 2.18% 17
2017
Q2
$11.1M Sell
85,260
-6,249
-7% -$766K 2.03% 26
2017
Q1
$11.4M Buy
+91,509
New +$11M 2.15% 22

Other funds holding CELG

Ninety One North America's CELG Position: Q1 2018 in Review

Ninety One North America sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 71,843 shares — an estimated $7.5M sold.

Ninety One North America first reported a position in CELG in Q1 2017 and held it in 4 quarters. The position peaked at $12.9M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Ninety One North America reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Ninety One North America sold 71,843 Celgene Corp shares in Q1 2018, an estimated $7.5M.
  • Ninety One North America first reported a position in Celgene Corp in Q1 2017 and held it in 4 quarters.
  • Ninety One North America's Celgene Corp position peaked at $12.9M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Ninety One North America's 13F filing for Q1 2018, filed 15 May 2018.